1. Home
  2. VHC vs TIL Comparison

VHC vs TIL Comparison

Compare VHC & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

HOLD

Current Price

$11.57

Market Cap

46.0M

Sector

Miscellaneous

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$7.36

Market Cap

52.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHC
TIL
Founded
2005
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.0M
52.2M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
VHC
TIL
Price
$11.57
$7.36
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$125.00
AVG Volume (30 Days)
74.3K
5.8K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
0.99
6.06
EPS
N/A
N/A
Revenue
$162,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3140.00
N/A
52 Week Low
$9.82
$5.67
52 Week High
$29.00
$25.89

Technical Indicators

Market Signals
Indicator
VHC
TIL
Relative Strength Index (RSI) 41.95 44.93
Support Level $10.84 $6.91
Resistance Level $18.44 $7.50
Average True Range (ATR) 1.04 0.25
MACD -0.11 -0.02
Stochastic Oscillator 28.98 2.00

Price Performance

Historical Comparison
VHC
TIL

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. Its software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: